Syndax Pharmaceuticals Q1 2026 Earnings Narrowed Loss Beats Estimates as Pipeline Progress Continues NVAX Q1 2026 Earnings Surprise EPS Beat Amidst Revenue Disruption Viridian Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Thyroid Eye Disease Pipeline RCMT Q1 2026 Earnings EPS Misses Estimates Stock Declines STXS Q1 2026 Earnings LargerThanExpected Loss as Company Continues Strategic Transition RWT Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction